Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,095,854
-
Total 13F shares
-
56,237,230
-
Share change
-
+751,626
-
Total reported value
-
$8,094,090,864
-
Put/Call ratio
-
191%
-
Price per share
-
$143.94
-
Number of holders
-
427
-
Value change
-
+$105,844,498
-
Number of buys
-
178
-
Number of sells
-
219
Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2024
As of 31 Dec 2024,
REPLIGEN CORP - COMMON STOCK (RGEN) was held by
427 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,237,230 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Champlain Investment Partners, LLC, SANDS CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, CITADEL ADVISORS LLC, MACQUARIE GROUP LTD, and Impax Asset Management Group plc.
This page lists
428
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.